» Articles » PMID: 21910069

Association of Chinese Medicine Constitution Susceptibility to Diabetic Nephropathy and Transforming Growth Factor-β1 (T869C) Gene Polymorphism

Overview
Date 2011 Sep 13
PMID 21910069
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To explore the association of Chinese medicine constitution susceptibility to diabetic nephropathy (DN) and transforming growth factor (TGF)-β1 (T869C) gene polymorphism.

Methods: TGF-β1 gene polymorphism detected with polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was screened for 180 DN cases and 180 type 2 diabetic mellitus (T2DM) cases without combined DN. Patients with DN were surveyed epidemiologically with constitution in the Chinese medicine questionnaire (CCMQ). Binary logistic regression analysis was utilized to study the correlation between nine types of Chinese medicine constitution and TGF-β1 (T869C) gene polymorphisms.

Results: The DN group has a higher frequency of TGF-β1 (T869C) gene polymorphism than the T2DM group, and CC/CT genotypes than the T2DM group [CC, CT, TT (DN group): 88, 87, 5 (cases) versus (T2DM group) 71, 73, 36 (cases), P<0.05]. The phlegm-dampness constitution, damp-heat constitution, and blood stasis constitution have correlations with TGF-β1 (T869C) gene polymorphism.

Conclusion: Chinese medicine constitutions were associated with TGF-β1 (T869C) gene polymorphism, a potential predictor of susceptibility to DN in T2DM patients.

Citing Articles

Valid and Convenient Questionnaire Assessment of Chinese Body Constitution: Item Characteristics, Reliability, and Construct Validation.

Lu T, Yan J, Chang J, Cai J, Yin L, Yuan J Patient Prefer Adherence. 2022; 16:1875-1884.

PMID: 35942226 PMC: 9356699. DOI: 10.2147/PPA.S373512.


Relationship between transforming growth factor-β1 and type 2 diabetic nephropathy risk in Chinese population.

Zhou T, Li H, Zhong H, Zhong Z BMC Med Genet. 2018; 19(1):201.

PMID: 30458730 PMC: 6247505. DOI: 10.1186/s12881-018-0717-3.


Different Risk Indictors of Diabetic Nephropathy in Transforming Growth Factor-beta1 T869C CC/CT Genotype and TT Genotype.

Mou X, Liu Y, Zhou D, Hu Y, Ma G, Shou C Iran J Public Health. 2016; 45(6):761-7.

PMID: 27648419 PMC: 5026831.


Association of transforming growth factor-β1 polymorphisms with the risk of diabetes mellitus.

Mao S, Zhang J, Zhao M, Zhang Y Int J Clin Exp Med. 2016; 8(11):21886-92.

PMID: 26885158 PMC: 4724004.


Yang Deficiency Body Constitution Acts as a Predictor of Diabetic Retinopathy in Patients with Type 2 Diabetes: Taichung Diabetic Body Constitution Study.

Lee C, Li T, Tsai C, Lin S, Lee I, Lee H Evid Based Complement Alternat Med. 2015; 2015:940898.

PMID: 26167195 PMC: 4475744. DOI: 10.1155/2015/940898.


References
1.
Bayat A, Bock O, Mrowietz U, Ollier W, Ferguson M . Genetic susceptibility to keloid disease and hypertrophic scarring: transforming growth factor beta1 common polymorphisms and plasma levels. Plast Reconstr Surg. 2003; 111(2):535-43; discussion 544-6. DOI: 10.1097/01.PRS.0000041536.02524.A3. View

2.
Atkins R, Zimmet P . Diabetic kidney disease: act now or pay later. Arch Iran Med. 2009; 13(1):77-80. View

3.
Mason R, Wahab N . Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol. 2003; 14(5):1358-73. DOI: 10.1097/01.asn.0000065640.77499.d7. View

4.
Lysaght M . Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol. 2002; 13 Suppl 1:S37-40. View

5.
Wong T, Poon P, Chow K, Szeto C, Cheung M, Li P . Association of transforming growth factor-beta (TGF-beta) T869C (Leu 10Pro) gene polymorphisms with type 2 diabetic nephropathy in Chinese. Kidney Int. 2003; 63(5):1831-5. DOI: 10.1046/j.1523-1755.2003.00919.x. View